Contact Us
Sign In / Sign Up for FREE
Go to advanced search...

Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction - Research Paper Example

Comments (0) Cite this document
Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction Abstract: Acute myocardial infarction can be treated using streptokinase. Streptokinase is derived from Streptococci. This Enzyme is a protein that binds to the plasmingoen and induces the thrombolysis…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER96.6% of users find it useful
Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction
Read TextPreview

Extract of sample "Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction"

Download file to see previous pages The administration of aspirin and heparin before the treatment will increase the survival rate. Introduction: Acute myocardial infraction is the breakdown of the heart muscles due to the lack of oxygen supply. The shortage in oxygen supply is caused by the collection of lipids at the heart muscles. This creates a block in the blood vessels resulting in ischemia and if left untreated it results in infraction of the myocardial cells. The risk factors of acute myocardial infarction (AMI) are cardiovascular disease, tobacco smoking, older age, kidney diseases, blood pressure, excessive alcohol consumption and obesity. Streptokinase is one of the first thrombolytic agent to be used for the treatment of Acute myocardial infarction. Streptokinase was discovered in the year 1933 by Dr. William Smith Tillett. The use of Streptokinase for the treatment of acute myocardial infarction started in the year 1947 when Sol Sherry identified the potential of streptokinase. (Sikri and Bardia, 2007).The clinical trials using streptokinase started thereafter. They concluded that streptokinase can be used to treat hemothorax, purulent and sanguineous pleural exudations, fibrinous and tuberculosis meningitis. (Sikri and Bardia, 2007).The difficulties in purifying the protein streptokinase led to the delay in the intravenous use. The intravenous use of streptokinase was started in the year 1952. This proved to be a promising approach. ...
Streptokinase binds to the circulating plasminogen and forms a complex. This complex activates the plasminogen through a three step mechanism. If fibrin is present, then the streptokinase – plasmin complex forming capacity gets increased and thus lyses the clots. (Becker, 1997). After infusion of the clot, the streptokinase spreads through the plasma. There are two phases of streptokinase clearance. The half life of first phase streptokinase is 11-17 minutes and that of the second phase is 85 minutes. The current recommended dose level of streptokinase is 1.5 million units for 30- 60 minutes. (Becker, 1997). The main drawback of streptokinase is that it is antigenic. The administration of streptokinase produces antibodies in the blood. The antibodies formed may neutralize the drug. (Becker, 1997). Development: After the discovery of Streptokinase in the year 1933, the mechanisms of action of streptokinase in humans were determined. In 1959, Ruegsegger discovered the intracoronary clots. Many clinical trials were conducted at this time. There was a small risk of allergy. Many investigators considered this to be the plausible option for the treatment of acute myocardial infraction. In the year 1985 many small trials were conducted to standardize the protocol for streptokinase but no trial produced positive result. Finally they concluded that when the drug was administered for 1.5 to 3 hours, they were able to receive reperfusion rate of 90%. (Sikri and Bardia, 2007). GISSI Trial: Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico ( GISSI) trial was conducted as the large scale trial. 11806 patients were enrolled in the study for a period of 17 months in 176 coronary heart care centre. New patients were recruited at a rate of ...Download file to see next pagesRead More
Cite this document
  • APA
  • MLA
(“Pharmacology Effectiveness of streptokinase in Acute Miocardial Research Paper”, n.d.)
Retrieved from
(Pharmacology Effectiveness of Streptokinase in Acute Miocardial Research Paper)
“Pharmacology Effectiveness of Streptokinase in Acute Miocardial Research Paper”, n.d.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document

CHECK THESE SAMPLES OF Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction

Acute Myocardial Infarction a dose greater than or equal to 160 mg to all patients (provided they have no known hypersensitivity) with suspected acute coronary syndrome or acute myocardial infarction (AMI). The second International Study of Infarct Survival (ISIS-2) demonstrated that acetylsalicylic acid alone reduced the mortality of evolving acute myocardial infarction by 23%. It is established that Acetylsalicylic acid inhibits platelet aggregation by an almost complete inhibition of thromboxane A2 production. Morphine sulfate given intravenously in 2- 4mg increments is the chosen analgesic agent because of its potency, safety when given intravenously, devoid...
12 Pages(3000 words)Essay

Evolution of Stable Angina into Acute Myocardial Infarction

... Evolution of Stable Angina into Acute Myocardial Infarction Introduction Stabile angina pectoris is a symptom that is associated with coronary vascular disease. It is a subjective feeling of chest pain, pressure, burning sensation or some other subjective feeling described by the patient that usually appears after physical exercise, intense emotional stimulus, stress or other provoking factor (Somerville et al. 2008). It is very variable symptom that varies when is described by different patients, and this makes it one of the most controversial symptoms in the medicine (Melvyn et al. 2010). Stabile angina pectoris is usually first recognized during a general practice (GP) doctor visit, or is noticed...
12 Pages(3000 words)Essay

Pharmacology the design and planning of new drugs and for biometric synthesis development and discovery of new medicinal properties that are currently not attributed to known compounds. Compounds acquired from plants such as muscarine, cannabinoids, forskolin and phorbol esters are used in the studies dealing with pharmacological, biochemical and physiological research. There is growing interest in use of drugs from natural sources and especially those that are derived from plants. This change towards inclination to natural products as drugs is as a result of various advantages observed in use of these products. Convectional medicines are at times ineffective resulting in side effects. When inappropriately...
13 Pages(3250 words)Essay

Miocardial Infarction Research Paper

...? Myocardial Infarction Myocardial Infarction (MI) is considered an irreparable myocardial cell death ensuing from ischemia. Myocardial ischemia goes beyond the threshold value and as a result cellular repair does not occur. MI or AMI (Acute Myocardial Infarction) occurs when the blood supply to a specific part of the heart is intervallic. Various diagnostic features aid in determining MI; these include sustaining regional ST rise through ECG, cardiac enzyme studies etc. In developed nations like the United States, deaths from heart disease are more abundant than the mortality from cancer. One in five deaths in the United States is due to coronary heart attacks. It is...
3 Pages(750 words)Research Paper


...and other acute illness, the binding of lignocaine to plasma proteins is increased. This is because of increase the concentration of plasma alpha-1 glycoprotein. Plasma alpha-1 glycoprotein is an acute phase reactant protein. It binds lignocaine thus reducing the concentration of the free drug available to exert its pharmacological effects. In these diseases, higher doses of the drug are recommended to exert it effects (Sophie & Rogers, 2008). In addition to binding to plasma, the drug is lipophillic thus has high affinity for fat and adipose tissue. State the volume of distribution (V) in either L/kg or Litres The volume of distribution of the drug is...
9 Pages(2250 words)Essay


...taken for the stomach to empty its contents into the ileum, thus, postponing absorption. Intestinal motility is also crucial when bringing the drug into contact with the cells of the epithelium for absorption. The duration of contact between the cells the drug should be adequate to promote absorption. For absorption to be successful, the flow of blood should be high for maximum absorption. Blood determines the diffusion gradient. Other factors that affect the rate of drug absorption include: the food we eat, the pH of the gastrointestinal environment, age and state of health (Washington, 2000). Question 2 The half life of a drug is the time it takes to for a drug to move from full pharmacological, physiological and...
3 Pages(750 words)Assignment


...? Pharmacology Administration of medication in hospitals requires a lot more than giving patients their medication. According to the AFH rules, caregivers must always be aware of every patient’s medication administration schedule, why the patient is being given the medication, its effects and any side effects that could arise. Medication administration process includes getting medical orders, writing medical orders on the (MAR) medical administration record, comparing the medical orders with the ones on the MAR to ensure they are correct, delivering and administering the medication to the patients, monitoring the patient’s progress and recording, storing and getting rid of expired, unused...
4 Pages(1000 words)Assignment

Acute Myocardial Infarction

...Acute Myocardial Infarction Nursing Case Order 187961 Total Price: $50 Messages: 0 total Topic: Formal Nursing Research Paper request nursing professional Instructions: 10/21/07 Formal Research Paper Each paper will cover a disease process. Select one disease process and complete a research paper on the disease chosen. There must be 6 references for the paper: - 3 of which must be professional journal articles - 2 from a web site - 1 from a text or nursing book. Be aware the references, unless a classic, must be current (5yrs or less). This paper counts as 15% of your final grade. Papers will not be accepted after November 15, 2007 by 1700. Guidelines - Computer generated with correct spelling, grammar... ...
5 Pages(1250 words)Essay

Beta-Blockers for Acute Myocardial Infarction

...., ) or newer beta-blockers such as carvedilol and nebivolol. References Agency for Healthcare Research and Quality. (2005, April). Beta-Blockers for Acute Myocardial Infarction. Retrieved April 26, 2008, from Fact Sheet: Bonnemeier, H., Ortak, J., Tlg, R., Witt, M., Schmidt, J., Wiegand, U. K. H., et al. (2005). Carvedilol Versus Metoprolol in Patients Undergoing Direct Percutaneous Coronary Interventions for Myocardial Infarction: Effects on QT Dynamicity. Pacing and Clinical Electrophysiology , 28 (s1), S217-S221. British Heart Foundation. (2008). Myocardial Infarction (Heart Attack). Retrieved April 26,...
3 Pages(750 words)Essay

Acute Myocardial Infarction

...Acute Myocardial Infarction (AMI) Pathophysiology Figure Summary of the pathological processes involved in AMI Plaque Formation V Plaque Rupture : V Thrombosis : V Myocardial Ischemia : V Myocardial Infarction The start of the pathophysiology of acute coronary syndromes like AMI lies in the formation of plaque. The American Heart Association has named these plaques as developed human fibrolipid plaques. Such plaques form as a result of low density lipoproteins being oxidized and consumed by macrophages. In this process the macrophages are transformed into foam cells, which accumulate within the smooth muscle cell layer of coronary arteries to form plaque. Calcification...
2 Pages(500 words)Essay
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Research Paper on topic Pharmacology Effectiveness of streptokinase in Acute Miocardial Infarction for FREE!

Contact Us